The Embassy of Denmark in Seoul hosted a press conference for Biocare Copenhagen’s launch in Korea on Friday, Nov. 13 at the Shilla Hotel in Seoul. It was the first official introduction ofBiocare Copenhagen to the local press as well as Denmark’s global competency in the probiotics industry.
On the occasion, Per Okkel, permanent secretary of the Danish Ministry of Health, stated that, “The Danish government is encouraging a business environment where SME companies can invest in R&D to develop cutting-edge products. I understand that Korea is also focusing on the establishment of a ‘creative economy’ in order to grow SME companies and to develop R&D-based high technology products and services. I believe the example of Biocare Copenhagen can inspire many Korean companies and institutions in their venture to become business successes not only in Korea but also in overseas markets.”
Ambassador Lehmann shed light on the Danish and Korean trade that has developed almost explosively over the last couple of years. Danish exports to Korea grew by more than 50 percent during the first half of this year compared to the same period last year, and exports for the full year of 2014 grew by almost 20 percent. He also urged more Danish companies to take advantage of the Free Trade Agreement (FTA) between Korea and the EU that came into effect in 2011.
Presenters at the event included Permanent Secretary Per Okkels of the Danish Ministry of Health, Danish Ambassador Thomas Lehmann, Biocare Copenhagen CEO Soren Thomsen and Copenhagen University Hospital MD Michael Tvede.